Company intelligence / Profile preview

DiappyMed

Montpellier, Occitanie, Francediappymed.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

DiappyMed has developed EkiYou®, a CE-marked digital therapy that provides personalized insulin dose recommendations based on meal, physical activity, and blood glucose levels. Clinical trials have shown improved glycemic control ("time in range") for users. The company also offers EkiYou Carbs, an app for carbohydrate counting. Both solutions were co-developed with over 2,000 patients and a medical committee of experts.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital therapyMobile application (software as a medical device)
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

EkiYou

Commercial

Indications: Type 1 diabetes, Type 2 diabetes

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on DiappyMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiappyMed.

Explore the full profile